Latest filing published 15 Sept 2025 for DarioHealth Corp..
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven Charles Nelson appears in our data through filings on DarioHealth Corp. shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 19 August 2024 to 11 September 2025.
On the market, this insider has only ever bought: 12 purchases, €62k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2025: 1 purchase and no sales on the market.
Half of the purchases are above €4,168 and half below. Of 12 purchases, 10 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 4 purchases with a full 90-day history, the hit rate stands at 25% and the median 90-day move at -7.8%. These figures describe past trades and do not predict future prices.
On 15 September 2025 came the latest disclosure, a share grant in DarioHealth Corp. The clock since the last published purchase (27 August 2025) now reads 425 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations